Randomized, Double Blind, Placebo Controlled "First-in-human" Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-680 in Male Healthy Volunteers
Latest Information Update: 14 Jan 2020
At a glance
- Drugs PBF 680 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 May 2013 New trial record